LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4

被引:2367
作者
TIVOL, EA [1 ]
BORRIELLO, F [1 ]
SCHWEITZER, AN [1 ]
LYNCH, WP [1 ]
BLUESTONE, JA [1 ]
SHARPE, AH [1 ]
机构
[1] UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637
关键词
D O I
10.1016/1074-7613(95)90125-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The B7-CD28/CTLA-4 costimulatory pathway can provide a signal pivotal for T cell activation, Signaling through this pathway is complex due to the presence of two B7 family members, B7-1 and B7-2, and two counterreceptors, CD28 and CTLA-4. Studies with anti-CTLA-4 monoclonal antibodies have suggested both positive and negative roles for CTLA-4 in T cell activation, To elucidate the in vivo function of CTLA-4, we generated CTLA-4-deficient mice. These mice rapidly develop lymphoproliferative disease with multiorgan lymphocytic infiltration and tissue destruction, with particularly severe myocarditis and pancreatitis, and die by 3-4 weeks of age. The phenotype of the CTLA-4-deficient mouse strain is supported by studies that have suggested a negative role for CTLA-4 in T cell activation. The severe phenotype of mice lacking CTLA-4 implies a critical role for CTLA-4 in downregulating T cell activation and maintaining immunologic homeostasis. In the absence of CTLA-4, peripheral T cells are activated, can spontaneously proliferate, and may mediate lethal tissue injury.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 30 条
[1]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[2]   BLOCKADE OF THE CD28 COSTIMULATORY PATHWAY - A MEANS TO INDUCE TOLERANCE [J].
BOUSSIOTIS, VA ;
GRIBBEN, JG ;
FREEMAN, GJ ;
NADLER, LM .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) :797-807
[3]   LONG-TERM INHIBITION OF MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS USING CTLA-4-FC SUPPORTS A KEY ROLE FOR CD28 COSTIMULATION [J].
CROSS, AH ;
GIRARD, TJ ;
GIACOLETTO, KS ;
EVANS, RJ ;
KEELING, RM ;
LIN, RF ;
TROTTER, JL ;
KARR, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2783-2789
[4]   TREATMENT OF MURINE LUPUS WITH CTLA4IG [J].
FINCK, BK ;
LINSLEY, PS ;
WOFSY, D .
SCIENCE, 1994, 265 (5176) :1225-1227
[5]   UNCOVERING OF FUNCTIONAL ALTERNATIVE CTLA-4 COUNTER-RECEPTOR IN B7-DEFICIENT MICE [J].
FREEMAN, GJ ;
BORRIELLO, F ;
HODES, RJ ;
REISER, H ;
HATHCOCK, KS ;
LASZLO, G ;
MCKNIGHT, AJ ;
KIM, J ;
DU, LN ;
LOMBARD, DB ;
GRAY, GS ;
NADLER, LM ;
SHARPE, AH .
SCIENCE, 1993, 262 (5135) :907-909
[6]   CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION [J].
FREEMAN, GJ ;
GRIBBEN, JG ;
BOUSSIOTIS, VA ;
NG, JW ;
RESTIVO, VA ;
LOMBARD, LA ;
GRAY, GS ;
NADLER, LM .
SCIENCE, 1993, 262 (5135) :909-911
[7]  
FREEMAN GJ, 1992, J IMMUNOL, V149, P3795
[8]   MURINE B7-2, AN ALTERNATIVE CTLA4 COUNTER-RECEPTOR THAT COSTIMULATES T-CELL PROLIFERATION AND INTERLEUKIN-2 PRODUCTION [J].
FREEMAN, GJ ;
BORRIELLO, F ;
HODES, RJ ;
REISER, H ;
GRIBBEN, JG ;
NG, JW ;
KIM, J ;
GOLDBERG, JM ;
HATHCOCK, K ;
LASZLO, G ;
LOMBARD, LA ;
WANG, S ;
GRAY, GS ;
NADLER, LM ;
SHARPE, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2185-2192
[9]  
GREENFIELD CL, 1994, P NATL ACAD SCI USA, V92, P811
[10]  
HARPER K, 1991, J IMMUNOL, V147, P1037